New Mobile Oncology Decision Support Solution for R&D Pharma Leaders
We recently announced the release of a new oncology app for mobile tablet devices. It has a rich visualization dashboard that uses content from Thomson Reuters Cortellis, our flagship life sciences platform. The app provides real-time data and is already being used by AstraZeneca, a Thomson Reuters partner.
The solution provides a series of oncology-based clinical dashboards that provide competitive information that quickly answers common questions in drug development. As a sign of the way forward, mobile tablet-based devices are the main method for accessing this solution. It is platform independent and accessible via the internet.
Read the full press release.